SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-124746
Filing Date
2020-04-29
Accepted
2020-04-29 09:01:27
Documents
8
Period of Report
2020-06-17
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d866705ddef14a.htm DEF 14A 418259
2 GRAPHIC g866705g11y77.jpg GRAPHIC 26592
3 GRAPHIC g866705g16l73.jpg GRAPHIC 26500
4 GRAPHIC g866705g21j11.jpg GRAPHIC 24658
5 GRAPHIC g866705g56z83.jpg GRAPHIC 16586
6 GRAPHIC g866705g57f70.jpg GRAPHIC 22487
7 GRAPHIC g866705g58d40.jpg GRAPHIC 37709
8 GRAPHIC g866705g66g95.jpg GRAPHIC 29746
  Complete submission text file 0001193125-20-124746.txt   670262
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36199 | Film No.: 20827660
SIC: 2834 Pharmaceutical Preparations